ANANDAMIDE/THC INDUCED ARACHIDONIC ACID RELEASE
ANANDAMIDE/THC INDUCED ARACHIDONIC ACID RELEASE
批准号:
2668143
负责人:
SUMNER HOWARD BURSTEIN
金额:
$16.06万
依托单位国家:
美国
项目类别:
财政年份:
1995
资助国家:
美国
项目状态:
已结题
起止时间:
1995-03-15 至 2000-02-29
中文摘要
本应用程序中提出的实验目标是确定
英文摘要
The goal of the experiments proposed in this application is to determine
the biochemical events that lead to cannabinoid-induced arachidonic acid
release. The studies to be carried out will be focused on the signal
transduction processes following cannabinoid binding to its receptor. The
question of receptor mediation in this process will be addressed by the
use of anti sense oligodeoxynucleotides in addition to the more
conventional ligand binding approach. Oligos will be designed to reduce,
or eliminate completely, the expression of the cannabinoid receptor genes
and compared with subsequent changes in arachidonic acid release. The term
cannabinoid is meant to include both exogenous substances, such as THC,
and endogenous molecules like anandamide. The systems to be used for these
investigations will be isolated, intact cells such as mouse peritoneal
macrophages, neuroblastoma and Chinese-hamster ovary lines. The
experiments are aimed at defining roles for phospholipase D, protein
kinase C, MAP kinase and phospholipase A2 in mediating cannabinoid-
stimulated release of arachidonic acid and the subsequent production of
eicosanoids. Direct measurement of enzyme activities will be made over a
range of cannabinoid concentrations and compared with arachidonic acid
release under identical conditions. Time course studies will also be done
to help elucidate the sequence of events involved. Specific inhibitors of
the various enzymes will be used where possible to supplement the data
obtained by direct measurement.
Eicosanoids, such as prostaglandin E2, have been shown to be important
mediators of cannabinoid action in humans as well as in animal models so
that a detailed understanding of how their levels are elevated is of
importance. The recent discovery of an endogenous cannabinoid, anandamide,
that may function as a brain neuroregulator, lends even greater
significance to the aims of this proposal because of its structural
nature, namely, the ethanolantide derivative of arachidonic acid. The
significance of the anandamide discovery to the "prostaglandin hypothesis"
of cannabinoid action is not clear at this time, however, it is unlikely
that the eicosanoid nature of anandamide is only coincidental. A better
understanding of THC/anandamide biochemical actions could improve our
understanding of processes such as memory, motor coordination cognitive
ability, time sense and self-perception. In addition, some insight might
be gained into the question of the molecular basis for cannabis abuse. The
recent reports on the increasing use of marihuana, especially among
preadolescents, has again focussed attention on efforts to understand the
actions of this drug.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The elmiric acids: biologically active anandamide analogs.
-
批准号:7727687
-
项目类别:
-
资助金额:$33.98万
-
财政年份:2009
-
负责人:SUMNER HOWARD BURSTEIN
-
依托单位:
The elmiric acids: biologically active anandamide analogs.
-
批准号:7894890
-
项目类别:
-
资助金额:$32.43万
-
财政年份:2009
-
负责人:SUMNER HOWARD BURSTEIN
-
依托单位:
Endocannabinoid Analogs as Anti-inflammatory Agents
-
批准号:7106374
-
项目类别:
-
资助金额:$11.86万
-
财政年份:2004
-
负责人:SUMNER HOWARD BURSTEIN
-
依托单位:
Endocannabinoid Analogs as Anti-inflammatory Agents
-
批准号:6951593
-
项目类别:
-
资助金额:$12.15万
-
财政年份:2004
-
负责人:SUMNER HOWARD BURSTEIN
-
依托单位:
Endocannabinoid Analogs as Anti-inflammatory Agents
-
批准号:6749403
-
项目类别:
-
资助金额:$12.15万
-
财政年份:2004
-
负责人:SUMNER HOWARD BURSTEIN
-
依托单位:
Endocannabinoid Analogs as Anti-inflammatory Agents
-
批准号:7678732
-
项目类别:
-
资助金额:$2.92万
-
财政年份:2004
-
负责人:SUMNER HOWARD BURSTEIN
-
依托单位:
NON PSYCHOACTIVE CANNABINOIDS WITH THERAPEUTIC POTENTIAL
-
批准号:6175550
-
项目类别:
-
资助金额:$23.86万
-
财政年份:1999
-
负责人:SUMNER HOWARD BURSTEIN
-
依托单位:
NON PSYCHOACTIVE CANNABINOIDS WITH THERAPEUTIC POTENTIAL
-
批准号:2902241
-
项目类别:
-
资助金额:$23.17万
-
财政年份:1999
-
负责人:SUMNER HOWARD BURSTEIN
-
依托单位:
NON PSYCHOACTIVE CANNABINOIDS WITH THERAPEUTIC POTENTIAL
-
批准号:6378830
-
项目类别:
-
资助金额:$24.58万
-
财政年份:1999
-
负责人:SUMNER HOWARD BURSTEIN
-
依托单位:
NON PSYCHOACTIVE CANNABINOIDS WITH THERAPEUTIC POTENTIAL
-
批准号:6515659
-
项目类别:
-
资助金额:$25.2万
-
财政年份:1999
-
负责人:SUMNER HOWARD BURSTEIN
-
依托单位:
BIOSYNTHESIS OF ANANDAMIDE--A NOVEL EICOSANOID
-
批准号:2122673
-
项目类别:
-
资助金额:$16.13万
-
财政年份:1995
-
负责人:SUMNER HOWARD BURSTEIN
-
依托单位:
ANANDAMIDE/THC INDUCED ARACHIDONIC ACID RELEASE
-
批准号:2121953
-
项目类别:
-
资助金额:$15.04万
-
财政年份:1995
-
负责人:SUMNER HOWARD BURSTEIN
-
依托单位:
ANANDAMIDE/THC INDUCED ARACHIDONIC ACID RELEASE
-
批准号:2377395
-
项目类别:
-
资助金额:$15.44万
-
财政年份:1995
-
负责人:SUMNER HOWARD BURSTEIN
-
依托单位:
BIOSYNTHESIS OF ANANDAMIDE--A NOVEL EICOSANOID
-
批准号:2122674
-
项目类别:
-
资助金额:$16.57万
-
财政年份:1995
-
负责人:SUMNER HOWARD BURSTEIN
-
依托单位:
ANANDAMIDE/THC INDUCED ARACHIDONIC ACID RELEASE
-
批准号:2882593
-
项目类别:
-
资助金额:$16.7万
-
财政年份:1995
-
负责人:SUMNER HOWARD BURSTEIN
-
依托单位:
ANANDAMIDE/THC INDUCED ARACHIDONIC ACID RELEASE
-
批准号:2121952
-
项目类别:
-
资助金额:$15.03万
-
财政年份:1995
-
负责人:SUMNER HOWARD BURSTEIN
-
依托单位:
BIOSYNTHESIS OF ANANDAMIDE--A NOVEL EICOSANOID
-
批准号:2443494
-
项目类别:
-
资助金额:$17.23万
-
财政年份:1995
-
负责人:SUMNER HOWARD BURSTEIN
-
依托单位:
PROSTAGLANDIN & CANNABIS
-
批准号:2116494
-
项目类别:
-
资助金额:$5.54万
-
财政年份:1977
-
负责人:SUMNER HOWARD BURSTEIN
-
依托单位:
PROSTAGLANDIN & CANNABIS
-
批准号:3207098
-
项目类别:
-
资助金额:$6.9万
-
财政年份:1977
-
负责人:SUMNER HOWARD BURSTEIN
-
依托单位:
MECHANISM OF ACTION OF CANNABIS
-
批准号:3075330
-
项目类别:
-
资助金额:$5.36万
-
财政年份:1977
-
负责人:SUMNER HOWARD BURSTEIN
-
依托单位:
海外基金